Reversal of Chloroquine Resistance of Plasmodium vivax in Aotus Monkeys
Chloroquine-resistant (CQR) vivax malaria has emerged as a threat to the malaria elimination agenda. The objective of this study was to assess if a combination of chloroquine (CQ) and prochlorperazine was able to reverse CQ resistance of the AMRU-1 strain from Papua New Guinea in infected monkeys. F...
Saved in:
Published in | Antimicrobial agents and chemotherapy Vol. 62; no. 9 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.09.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Chloroquine-resistant (CQR) vivax malaria has emerged as a threat to the malaria elimination agenda. The objective of this study was to assess if a combination of chloroquine (CQ) and prochlorperazine was able to reverse CQ resistance of the
AMRU-1 strain from Papua New Guinea in infected
monkeys. For this purpose, in two independent experimental drug efficacy trials, a total of 18
monkeys infected with blood obtained from donor animals were randomly assigned to treatment and control groups and orally administered CQ at 10 mg/kg or prochlorperazine at 20 mg/kg, alone or in combination, for five consecutive days. Reversal of CQR was achieved in animals that received the drug combination, whereas neither drug alone produced cures. This same drug combination reverses CQR in
and could be an alternative for treatment in humans with chloroquine-resistant
infections. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Wilbur K. Milhous, Clemson University, College of Science, Clemson, South Carolina, USA. Citation Obaldia N III, Milhous WK, Kyle DE. 2018. Reversal of chloroquine resistance of Plasmodium vivax in Aotus monkeys. Antimicrob Agents Chemother 62:e00582-18. https://doi.org/10.1128/AAC.00582-18. |
ISSN: | 0066-4804 1098-6596 |
DOI: | 10.1128/AAC.00582-18 |